Advertisement
Research ArticleArticle

Polymorphic Variants (CYP2C9*3 and CYP2C9*5) and the F114L Active Site Mutation of CYP2C9: Effect on Atypical Kinetic Metabolism Profiles

Timothy S. Tracy, J. Matthew Hutzler, Robert L. Haining, Allan E. Rettie, Matthew A. Hummel and Leslie J. Dickmann
Drug Metabolism and Disposition April 2002, 30 (4) 385-390; DOI: https://doi.org/10.1124/dmd.30.4.385
Submit a Response to This Article
Compose eLetter

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Statement of Competing Interests

Vertical Tabs

Jump to comment:

No eLetters have been published for this article.
Back to top

In this issue

Download PDF
Article Alerts
Email Article
Citation Tools

Research ArticleArticle

Polymorphic Variants (CYP2C9*3 and CYP2C9*5) and the F114L Active Site Mutation of CYP2C9: Effect on Atypical Kinetic Metabolism Profiles

Timothy S. Tracy, J. Matthew Hutzler, Robert L. Haining, Allan E. Rettie, Matthew A. Hummel and Leslie J. Dickmann
Drug Metabolism and Disposition April 1, 2002, 30 (4) 385-390; DOI: https://doi.org/10.1124/dmd.30.4.385
Reddit logo Twitter logo Facebook logo Mendeley logo

Jump to section

Advertisement